Barristers

A judge has handed Shinetec a win in its dispute with the developer of a scuttled $185 million project in Sydney, finding that $48 million owed by the builder to its parent company after the developer called on a letter of credit fell within the definition of ‘secured money’.

An appeals court has confirmed that mining companies AngloGold and IGO Limited did not need to renegotiate native title approvals when they consolidated 31 existing mining leases into a single lease. 

A judge has ordered trustee United Super to pay $23.5 million after admitting it was liable for excessive delays in processing $20 million in death and disability claims.

The publisher of The Australian will bring a truth defence to defamation claims by two sacked executives of commercial real estate broker JLL who claim they were falsely accused of sexual harassment, a court has heard. 

Imposing a duty of care on the Australian government to protect Torres Strait Islanders from climate change would not involve the Federal Court in matters of political judgment, a failed class action has argued on appeal.

A superannuation fund has taken McCullough Robertson to court, arguing that its former solicitors failed to warn that a $33 million share sale agreement with Firecroft Technical Services could be jeopardised if a related Fair Work Commission approval was quashed. 

A court has upheld the $63.8 million valuation of an inner-Sydney high-rise, rejecting Meriton's argument that it should be reduced to $52 million because of its isolation from public transport.

A Sydney builder has lost its challenge to a $453,000 judgment for a developer, with an appeals court finding the construction company claimed payment for a greater amount of work than was done on a project in Dural. 

Famed restaurant chain Momofuku has filed an appeal after losing its challenge to a trade mark of instant noodle giant Nissin Foods, a court has heard.

German pharmaceutical company Heidelberg Pharma has filed a lawsuit against Australian drug maker Telix alleging breach of a licence agreement for its kidney cancer diagnostic drug Zircaix.